<DOC>
	<DOCNO>NCT00379067</DOCNO>
	<brief_summary>Randomized , double-blind , placebo-controlled study two treatment arm ( Tamsulosin OCAS 0.4 mg &amp; placebo ) . The study comprise 2-week placebo run-in follow 12-week treatment period .</brief_summary>
	<brief_title>A Phase 4 Study With Tamsulosin OCAS Assess Nighttime Voiding .</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Diagnosed LUTS associated BPH On average , least 2 void per night last week A maximum 4 hour undisturbed sleep expect per night ( night time define time go bed purpose sleep wake purpose get ) Subject currently take diuretic Subjects work shift hour whose hour work include time 23.00 06.00h</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Benign Prostatic Hyperplasia</keyword>
	<keyword>Nocturia</keyword>
	<keyword>Actigraphy</keyword>
	<keyword>Tamsulosin</keyword>
</DOC>